Matignon Technologies
Europe, Ile-de-France, France, Paris
Description
MT is a euro 50 M closed-end venture capital fund dedicated to investments in unlisted innovative, early-stage companies.
Investor Profile
Matignon Technologies has backed more than 8 startups, with 0 new investments in the last 12 months alone. The firm has led 2 rounds, about 25% of its total and boasts 2 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series Unknown, Series A rounds (top funding stages).
- Majority of deals are located in France, United States, United Kingdom.
- Strong thematic focus on Biotechnology, Health Care, Medical Device.
Stage Focus
- Series B (38%)
- Series Unknown (38%)
- Series A (13%)
- Series C (13%)
Country Focus
- France (50%)
- United States (38%)
- United Kingdom (13%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Industry Focus
- Biotechnology
- Health Care
- Medical Device
- Manufacturing
- Medical
- Wellness
- Life Science
- Therapeutics
- Sports
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
